Press release content from Business Wire. The AP news staff was not involved in its creation.
Hawaii PUC Approves Swell Energy’s Grid Services Contract with Hawaiian Electric
January 18, 2021 GMT
LOS ANGELES (BUSINESS WIRE) Jan 18, 2021
Swell Energy, Inc. today announced that the Hawaii Public Utilities Commission (PUC) has approved its $25 million contract with Hawaiian Electric for the delivery of various grid services through an aggregated “virtual power plant” (VPP) on three islands. Swell Energy, a California-based energy and smart grid solutions provider, will deploy behind-the-meter solar-powered home batteries to approximately 6,000 residential customers to create a comprehensive VPP on Oahu, Maui and Hawaii islands.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Neurotechnology Releases New SentiVeillance 8.0 SDK for Identification and Analytics Using Live and Video Streams
January 18, 2021 GMT
VILNIUS, Lithuania, Jan. 18, 2021 /PRNewswire/ Neurotechnology, a provider of deep-learning-based solutions and high-precision biometric identification and object recognition technologies, today announced the release of the SentiVeillance 8.0 software development kit (SDK). With SentiVeillance SDK, developers can create identification solutions that use live video streams from digital surveillance cameras or video files. The latest version adds face detection and recognition of people who are wearing masks and includes new algorithms that improve license plate detection and recognition speed and accuracy. It also provides new features for vehicle and human (VH) mode, including car make and model estimation, vehicle angle estimation and cloth and gender est
PRAGUE (AP) — PRAGUE — The fast-spreading coronavirus variant first identified in the U.K. has been found in the Czech Republic, a health official said Monday.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Propanc Biopharma Receives Expression of Interest to Evaluate Proenzyme Therapy in Pancreatic and Ovarian Cancer Patients
January 18, 2021 GMT
MELBOURNE, Australia (BUSINESS WIRE) Jan 18, 2021
Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Company has received expressions of interest to evaluate proenzyme therapy as a method to prevent recurrence and metastasis of solid tumors in pancreatic and ovarian cancers. The letters of interest were confirmed by Drs Natalia Luque Caro and Fernando Gálvez Montosa, medical oncologists specializing in pancreatic and ovarian cancers, respectively, from the University Hospital of Jaén, in Granada, Spain. The evaluation will most likely be conducted as separate Phase IIa proof